| A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients B Zhang, B Tang, J Gao, J Li, L Kong, L Qin Journal of Translational Medicine 18, 1-17, 2020 | 124 | 2020 |
| The miR-1224-5p/ELF3 axis regulates malignant behaviors of pancreatic cancer via PI3K/AKT/Notch signaling pathways L Kong, P Liu, M Zheng, Z Wang, Y Gao, K Liang, H Wang, X Tan OncoTargets and therapy 13, 3449, 2020 | 31 | 2020 |
| Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis P Liu, L Kong, H Jin, Y Wu, X Tan, B Song Cancer Cell International 19 (1), 1-10, 2019 | 29 | 2019 |
| Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer L Kong, P Liu, M Zheng, B Xue, K Liang, X Tan Epigenomics 12 (6), 507-524, 2020 | 28 | 2020 |
| Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach P Liu, L Kong, K Liang, Y Wu, H Jin, B Song, X Tan BMC cancer 20, 1-9, 2020 | 16 | 2020 |
| A prognostic prediction model developed based on four CpG sites and weighted correlation network analysis identified DNAJB1 as a novel biomarker for pancreatic cancer L Kong, P Liu, X Fei, T Wu, Z Wang, B Zhang, J Li, X Tan Frontiers in oncology, 1716, 2020 | 15 | 2020 |
| HOXB5 promotes proliferation, migration, and invasion of pancreatic cancer cell through the activation of the GSK3β/β-catenin pathway Y Gao, X Fei, L Kong, X Tan Anti-cancer drugs 31 (8), 828-835, 2020 | 13 | 2020 |
| Identification of novel metabolism-associated subtypes for pancreatic cancer to establish an eighteen-gene risk prediction model Y Gao, E Zhang, X Fei, L Kong, P Liu, X Tan Frontiers in Cell and Developmental Biology 9, 691161, 2021 | 12 | 2021 |
| Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription Z Yang, F Liu, Z Li, N Liu, X Yao, Y Zhou, L Zhang, P Jiang, H Liu, L Kong, ... Clinical Epigenetics 15 (1), 92, 2023 | 10 | 2023 |
| Identification of RE1-silencing transcription factor as a promoter of metastasis in pancreatic cancer H Jin, P Liu, L Kong, X Fei, Y Gao, T Wu, D Sun, X Tan Frontiers in Oncology 9, 291, 2019 | 10 | 2019 |
| Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer X Yin, L Kong, P Liu Clinical Epigenetics 13 (1), 109, 2021 | 9 | 2021 |
